Management Impact of FDG-PET in Dementia: Results from a Tertiary Center Memory Clinic
Alby Elias, Michael Woodward, Christopher C Rowe
JOURNAL OF ALZHEIMERS DISEASE | IOS PRESS | Published : 2014
BACKGROUND: 2-[18F]fluoro-2-Deoxy-D-glucose (FDG) positron emission tomography (PET) may assist the diagnosis of dementia but it is an expensive investigation. OBJECTIVE: To obtain management impact data for FDG-PET in dementia. METHODS: This was a prospective study of 194 consecutive patients referred from a memory clinic for FDG-PET at the discretion of the dementia specialists. Diagnosis and management plans formulated at a multidisciplinary patient review meeting were compared before and after the release of PET findings. RESULTS: FDG-PET had moderate to high impact on the diagnosis and management in 85 (44%) participants. Diagnosis changed from probable neurodegenerative disease in 27 p..View full abstract
We thank the medical, nursing, and allied health staff of the Austin Health Memory Disorders Clinic for their assistance with this study. Funding Source: The Victorian Government Department of Health and Human Services.